Announcements

16 August 2024
Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Cellular Biochemistry”


As all of the articles published in our journal Biomolecules (ISSN: 2218-273X) are open access, you have free and unlimited access to the full texts. We welcome you to read our most highly cited papers published in 2022 and 2023, which are listed below:

1. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives”
by Mariyam Khalid, Georg Petroianu and Abdu Adem
Biomolecules 2022, 12(4), 542; https://doi.org/10.3390/biom12040542
Full text available online: https://www.mdpi.com/2218-273X/12/4/542

2. “Metallothionein and Cadmium Toxicology—Historical Review and Commentary”
by Monica Nordberg and Gunnar F. Nordberg
Biomolecules 2022, 12(3), 360; https://doi.org/10.3390/biom12030360
Full text available online: https://www.mdpi.com/2218-273X/12/3/360

3. “Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer”
by Galina Zhulai, Eugenia Oleinik, Mikhail Shibaev and Kirill Ignatev
Biomolecules 2022, 12(3), 418; https://doi.org/10.3390/biom12030418
Full text available online: https://www.mdpi.com/2218-273X/12/3/418

4. “Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration”
by Reem H. ElSheikh, Muhammad Z. Chauhan and Ahmed B. Sallam
Biomolecules 2022, 12(11), 1629; https://doi.org/10.3390/biom12111629
Full text available online: https://www.mdpi.com/2218-273X/12/11/1629

5. “Bcl-2 Family Members and the Mitochondrial Import Machineries: The Roads to Death”
by Lisenn Lalier, François Vallette François Vallette and Stéphen Manon
Biomolecules 2022, 12(2), 162; https://doi.org/10.3390/biom12020162
Full text available online: https://www.mdpi.com/2218-273X/12/2/162

6. “The Disordered Dehydrin and Its Role in Plant Protection: A Biochemical Perspective”
by Margaret A. Smith and Steffen P. Graether
Biomolecules 2022, 12(2), 294; https://doi.org/10.3390/biom12020294
Full text available online: https://www.mdpi.com/2218-273X/12/2/294

7. “Co-Stimulatory Receptor Signaling in CAR-T Cells”
by Mackenzie M. Honikel and Scott H. Olejniczak
Biomolecules 2022, 12(9), 1303; https://doi.org/10.3390/biom12091303
Full text available online: https://www.mdpi.com/2218-273X/12/9/1303

8. “Galactosemia: Biochemistry, Molecular Genetics, Newborn Screening, and Treatment”
by Mariangela Succoio, Rosa Sacchettini, Alessandro Rossi, Giancarlo Parenti and Margherita Ruoppolo
Biomolecules 2022, 12(7), 968; https://doi.org/10.3390/biom12070968
Full text available online: https://www.mdpi.com/2218-273X/12/7/968

9. “Molecular Recognition of Proteins through Quantitative Force Maps at Single Molecule Level”
by Carlos Marcuello, Rocío de Miguel and Anabel Lostao
Biomolecules 2022, 12(4), 594; https://doi.org/10.3390/biom12040594
Full text available online: https://www.mdpi.com/2218-273X/12/4/594

10. “Cellular Senescence in Intervertebral Disc Aging and Degeneration: Molecular Mechanisms and Potential Therapeutic Opportunities”
by Prashanta Silwal, Allison M. Nguyen-Thai, Haneef Ahamed Mohammad, Yanshan Wang, Paul D. Robbins, Joon Y. Lee and Nam V. Vo
Biomolecules 2023, 13(4), 686; https://doi.org/10.3390/biom13040686
Full text available online: https://www.mdpi.com/2218-273X/13/4/686

15 August 2024
Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Bioinformatics and Systems Biology”


As all of the articles published in our journal Biomolecules (ISSN: 2218-273X) are open access, you have free and unlimited access to the full text. We welcome you to read our most highly cited papers published in 2022 and 2023, which are listed below:

1. “Boosting the Full Potential of PyMOL with Structural Biology Plugins”
by Serena Rosignoli and Alessandro Paiardini
Biomolecules 2022, 12(12), 1764; https://doi.org/10.3390/biom12121764
Full text available online: https://www.mdpi.com/2218-273X/12/12/1764

2. “Calcium Overload and Mitochondrial Metabolism”
by Lauren L. Walkon, Jasiel O. Strubbe-Rivera and Jason N. Bazil
Biomolecules 2022, 12(12), 1891; https://doi.org/10.3390/biom12121891
Full text available online: https://www.mdpi.com/2218-273X/12/12/1891

3. “Benchmarking the Accuracy of AlphaFold 2 in Loop Structure Prediction”
by Amy O. Stevens and Yi He
Biomolecules 2022, 12(7), 985; https://doi.org/10.3390/biom12070985
Full text available online: https://www.mdpi.com/2218-273X/12/7/985

4. “Protein Data Bank: A Comprehensive Review of 3D Structure Holdings and Worldwide Utilization by Researchers, Educators, and Students”
by Stephen K. Burley, Helen M. Berman, Jose M. Duarte, Zukang Feng, Justin W. Flatt, Brian P. Hudson, Robert Lowe, Ezra Peisach, Dennis W. Piehl, Yana Rose et al.
Biomolecules 2022, 12(10), 1425; https://doi.org/10.3390/biom12101425
Full text available online: https://www.mdpi.com/2218-273X/12/10/1425

5. “Predicting miRNA-Disease Association Based on Neural Inductive Matrix Completion with Graph Autoencoders and Self-Attention Mechanism”
by Chen Jin, Zhuangwei Shi, Ken Lin and Han Zhang
Biomolecules 2022, 12(1), 64; https://doi.org/10.3390/biom12010064
Full text available online: https://www.mdpi.com/2218-273X/12/1/64

6. “ECMpy, a Simplified Workflow for Constructing Enzymatic Constrained Metabolic Network Model”
by Zhitao Mao, Xin Zhao, Xue Yang, Peiji Zhang, Jiawei Du, Qianqian Yuan and Hongwu Ma
Biomolecules 2022, 12(1), 65; https://doi.org/10.3390/biom12010065
Full text available online: https://www.mdpi.com/2218-273X/12/1/65

7. “The Epigenetic Dimension of Protein Structure Is an Intrinsic Weakness of the AlphaFold Program”
by Fodil Azzaz, Nouara Yahi, Henri Chahinianand Jacques Fantini
Biomolecules 2022, 12(10), 1527; https://doi.org/10.3390/biom12101527
Full text available online: https://www.mdpi.com/2218-273X/12/10/1527

8. “The Metabolomic Approach for the Screening of Endometrial Cancer: Validation from a Large Cohort of Women Scheduled for Gynecological Surgery”
by Jacopo Troisi, Antonio Mollo, Martina Lombardi, Giovanni Scala, Sean M. Richards, Steven J. K. Symes, Antonio Travaglino, Daniele Neola, Umberto de Laurentiis, Luigi Insabato et al.
Biomolecules 2022, 12(9), 1229; https://doi.org/10.3390/biom12091229
Full text available online: https://www.mdpi.com/2218-273X/12/9/1229

9. “Saquinavir: From HIV to COVID-19 and Cancer Treatment”
by Mariana Pereira and Nuno Vale
Biomolecules 2022, 12(7), 944; https://doi.org/10.3390/biom12070944
Full text available online: https://www.mdpi.com/2218-273X/12/7/944

10. “Bioinformatics Prediction and Experimental Validation Identify a Novel Cuproptosis-Related Gene Signature in Human Synovial Inflammation during Osteoarthritis Progression”
by Wenjuan Wang, Ziyi Chen and Yinghui Hua
Biomolecules 2023, 13(1), 127; https://doi.org/10.3390/biom13010127
Full text available online: https://www.mdpi.com/2218-273X/13/1/127

12 August 2024
Prof. Dr. Benoit Coulombe Appointed Section Editor-in-Chief of Section “Biomacromolecules: Proteins” in Biomolecules

We are pleased to announce that Prof. Dr. Benoit Coulombe has been appointed Section Editor-in-Chief of the Section “Biomacromolecules: Proteins” in Biomolecules (ISSN: 2218-273X).

The Section “Biomacromolecules: Proteins” is at the interface between chemistry, biology, and molecular medicine. The Section has a strong focus on the structure and function of proteins, as well as their molecular mechanisms and biological and medical impacts. Basic research, in vitro and in vivo investigations, and pre-clinical studies are welcome.

Prof. Dr. Benoit Coulombe is a full research professor in the Department of Biochemistry and Molecular Medicine, Université de Montréal, Canada. His lab, located at the Institut de Recherches Cliniques de Montréal (IRCM), is developing state-of-the-art methods for high-sensitivity profiling of the human proteome at single-cell resolutions. More specifically, they aim to understand the folding and assembly of protein complexes by the HSP90/PAQosome chaperone machinery, as well as its dysregulation in various diseases.

The following is a short Q&A with Prof. Dr. Benoit Coulombe, who shared his vision for the journal with us, as well as his views on the research area and open access publishing:

1. What appealed to you about the journal that made you want to become its Section Editor-in-Chief?
Two things: (1) the highly rigorous and rapid review process, and (2) the open access approach.

2. What is your vision for this Section?
Proteins are the main functional actors of the cell, and their dysfunctions cause diseases. This makes this Section particularly important.

3. What does the future of this field of research look like?
This field is constantly expanding. Most significant are the new technology developments dealing with proteomics and structural modeling (AlphaFold).

4. Do you have any suggestions for young researchers in this field?
The pursuit of innovation is key for humanity.

5. What do you think of the development of open access publishing in the publishing field?
The development of OA is going in the right direction and journals like Biomolecules are important to push in this direction

We warmly welcome Prof. Dr. Benoit Coulombe as Section Editor-in-Chief for “Biomacromolecules: Proteins”, and we look forward to him leading Biomolecules to achieve many more milestones.

8 August 2024
Meet Us at the Biomolecular Horizons 2024 Congress (BMH 2024), 22–26 September 2024, Melbourne, Australia


MDPI will attend the Biomolecular Horizons 2024 Congress, held from 22 to 26 September 2024 in Melbourne, Australia. This important forum will bring together three prestigious congresses, each with a strong history of attracting the bioscience and biotechnology communities to discuss and examine the latest developments and research:

  • 26th Congress of the International Union of Biochemistry and Molecular Biology (IUBMB);
  • 17th Congress of the Federation of Asian & Oceanian Biochemists & Molecular Biologists (FAOBMB);
  • 22nd ComBio Conference (ComBio).

The overarching theme of the Biomolecular Horizons 2024 (BMH2024) Congress is “Discover, Create, Innovate”, which will be examined across the following key themes:

  • Cell, Developmental and Stem Cell Biology;
  • Biotechnology and Synthetic Biology;
  • Microbial World;
  • Cell Signalling and Metabolism;
  • Genomics, Gene Regulation and Epigenetics;
  • Bioinformatics, Computational Biology and Omics;
  • Structural Biology and Biophysics;
  • Molecular Basis of Disease;
  • Molecular Physiology;
  • Education.

The following MDPI journals will be represented:

If you are planning to attend the above conference, please feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any questions that you may have. For more information about the conference, please visit the following link: https://www.bmh2024.com/.

7 August 2024
MDPI Insights: The CEO's Letter #14 - New Headquarters, Marketing, Poland

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI Moves to New Headquarters in Basel, Switzerland

I am excited to share that MDPI has moved to a new state-of-the-art office space in Basel, Switzerland. This move consolidates our operations by bringing together our two previously separated Basel offices into one central location.

We are always growing our talent pool and encourage you to view our Careers Page for the positions available in Basel and across our offices.

New Address: Grosspeteranlage 5, CH-4052 Basel, Switzerland

Effective Date: 1 July 2024

This new chapter in our company’s journey is designed to continue our mission of positioning MDPI as a leader in Open Access (OA) publishing, highlighting our commitment to making scholarly research accessible to everyone.

Boasting modern amenities, improved meeting and event spaces designed to support our growing needs, the new location provides a more collaborative and efficient working environment for our employees. The location offers convenient accessibility to public transportation and is situated near the Basel SBB railway station, with a variety of nearby services and amenities.

In fact, I can see the trains right outside of my window as I write these lines!

This move marks an exciting milestone in MDPI’s development, and I am confident that the new headquarters will serve as an inspiring and productive space for everyone. We also very much look forward to welcoming visitors here. You can read more about MDPI's history here.

“This new chapter continues our mission of positioning MDPI as a leader in OA publishing”

For Those New to MDPI

A pioneer in scholarly, Open Access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to Open Science by making a greater proportion of the research conducted worldwide free and accessible to everyone. To date, over 3.5 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6,000 professional, well-trained staff members, and an in-house article submission platform designed to ensure efficient processes within its 440 fully Open Access titles. MDPI supports more than 800 academic institutions worldwide, helping them adhere to national mandates while facilitating authors’ publication in fully compliant (CC BY) Open Access journals.

Impactful Research

New and Emerging MDPI Journals Making an Immediate Impact

Unpacking some of the Impact Factor updates from the June CEO Letter, I wanted to dive a little deeper into the 137 MDPI journals which received Impact Factor for the first time.

Academic authors highly value efficient publishing processes, robust editorial support, and the opportunity to publish in high-impact journals. We are proud that our newly launched journals typically achieve coverage in the Emerging Sources Citation Index (ESCI) of the Web of Science within just a few years, with a median time of only three years from release to inclusion.

As part of our commitment to advancing academic research and providing high-quality OA publishing, we actively seek new research areas to expand our portfolio of journals. We have a proven track record of successfully establishing new journals.

Our dedicated teams excel in fostering dynamic editorial boards and working closely with Editors-in-Chief (EiC) to define the precise scope and focus of each new journal. Our expertise extends to collaborating with indexing services, ensuring that our journals comply with best practices and are indexed promptly in all relevant databases.

Emerging Titles Ranked for the First Time

Our commitment to excellence is reflected in the annual impact metrics released this past June. The latest edition of the Journal Citation Reports (JCR) showcases the integration of journals from the ESCI in the new unified category rankings, providing a simplified and more complete view of all journals within each subject category, including newly established titles.

Out of 137 new and developing MDPI journals ranked in the 2024 release, 79 are in the top half (Q1 or Q2) of their categories. Here is a breakdown of the number of MDPI’s ESCI-indexed journals by quartile in the JCR:

Quartile No. of journals
Q1 17 (12.4%)
Q2 62 (45.3%)
Q3 43 (31.4%)
Q4 15 (10.9%)
Not ranked (humanities-related journals) 2

These rankings highlight our success in rapidly establishing high-impact new journals. Among those that made it directly into the top 25% of their category are the International Journal of Neonatal Screening, Journal of Xenobiotics, Polysaccharides, Smart Cities, and thirteen other journals.

You can browse MDPI journals by Indexing. Simply visit our Journals page and select from the list of Indexing bodies in the top left-hand corner.

For quick reference, as at 31 July 2024:

Inside MDPI

MDPI Corporate Marketing Strategy and Team Meeting 2024

In July, I hosted the annual Corporate Marketing strategy and team-building activity with 15 of our team members.

The aim was to align the Corporate Marketing strategy with MDPI's goal of becoming the world's most trusted OA publisher. While we provide a high-level publishing experience for our authors, as seen from our surveys, we need to keep building on our transparent and open communication to foster trust within the scholarly community and continue enhancing our reputation.

The Corporate Marketing team plays an important role as the mouthpiece for all our major activities within MDPI, especially those that model what it means to be a trusted partner. The purpose of the strategy meeting was to develop a feeling of trust in one another and an understanding of how to inspire trust in the stakeholders with whom we interact.

“We need to keep building on our transparent and open communication to foster trust within the scholarly community”

We conducted a set of activities to facilitate that sense of mutual trust and trustworthiness. Examples of some activities we worked on during this strategy-building event include:

  • Exploring what trust means
    • ‘Letter to self’
    • ‘The brand I most trust’
  • Most Trusted Academic Publisher
    • ‘The brand I would like MDPI to become’
    • ‘The 2029 MDPI Annual Report’
    • Voice of Customer and Share of Voice – survey/data update on MDPI Brand Experience and Brand Perception
  • Integrate Trust-Based Objective into Marketing Plan
    • ‘Becoming the MDPI experience’
    • ‘Trusting the next steps’

While two days is not enough to finalize a marketing strategy, it is sufficient to get everyone who attended into the mindset of the direction in which we are working. From here, we will develop a program with next steps on main projects, update communications, and collaborate with team leads to incorporate this approach into our work going forward.

As a marketing team, we can communicate our messages, but trust has to be built at every touchpoint in the stakeholder journey. Just talking about it isn’t enough. We need to be about it. That’s a role each of us plays, from editorial to IT, from marketing to HR. We must build trust from the inside out. It starts with each manager and resonates out via every team member.

As a company, our goal is to give all stakeholders with whom we interact – whether internal or external – the experience of working with an organization it can trust.

Coming Together for Science

MDPI in Poland: Krakow Office

In July, I had the pleasure of visiting our Krakow office, following my recent trip to Warsaw to meet with the Polish Ministry of Science and Higher Education.

During these visits, I prioritized meeting with our Office Manager, Editorial Director, Group Leads, and members from various teams, including editorial, production, marketing, and journal relationship specialists, to understand their roles and current challenges. Instead of a formal presentation, I opted for an open discussion, sharing updates from headquarters to engage with colleagues in a more personal way.

Our Krakow office has many things to be proud of, including a large number of PhD colleagues (over a third of its staff holds a PhD degree). Krakow provides an opportunity for expanding beyond the 100 colleagues we currently have, by adding new hires in departments including editorial, production and marketing, among others.

About our Krakow office

  • Opened in 2020
  • 99 staff members as at 1 August 2024
  • Main Departments include Editorial, Production, English Department, JRS, PR

Our Krakow office participates in international conferences, conducts author trainings and scholar visits, and engages in local market outreach. The office is also a member of the Polish Chamber of Commerce for High Technology (IZTECH) and is working on expanding its local engagement.

Krakow is the second-largest city in Poland, with a population of about 800,000. It also has a large student population of around 128,000, with seven universities. This means that roughly one in every eight residents is a student.

Poland and MDPI

Poland is a crucial market for MDPI. From 2020 to June 2024, Poland ranked 7th in submissions and 5th in publications for MDPI research articles. As at 31 July 2024, Poland ranks 7th in total MDPI publications, with approximately 70,000 research papers.

Between 2020 and June 2024, 61,500 authors from Poland published with MDPI. As at 30 June 2024, there are 1,205 active Editorial Board Members (EBMs) from Poland, with 661 EBMs (55% of the total) having an H-index over 25.

We also have four Editors-in-Chief (EiC) from Poland leading our journals: Coatings, Venereology, Advances in Respiratory Medicine, and Limnological Review, along with six Section EiC.

In 2023, we received approximately 21,000 submissions from Polish-affiliated authors, of which 12,032 were published.

“Poland is a crucial market for MDPI”

Meeting with Ministry of Education

On 22 July, we visited Warsaw to meet with the Polish Ministry of Science and Higher Education.

We were pleased to learn that they are strong supporters of the OA publishing model and value MDPI’s approach to the peer-review process, including our high ethical standards for quality control.

In 2023 Polish authors predominantly published their papers in OA, with MDPI holding the largest market share in OA publications within the country.

Our commitment to collaborating with Polish institutions is evident through our 33 Institutional Open Access Program (IOAP) agreements with prestigious institutions such as the University of Warsaw, the University of Wroclaw, the Jagiellonian University, and Gdańsk University of Technology. Through IOAP discounts, a healthy waiver rate, and our peer-review voucher system, we provide the Polish scholarly community with significant savings in OA publishing. The Minister greatly appreciated these efforts and our commitment to offsetting some of the APC costs.

We discussed industry concerns about the threat of papermills and presented the preventive measures MDPI has in place to mitigate this risk and uphold high ethical standards. We informed them of our commitment to combating papermills, including our involvement with United2Act and the STM Research Integrity Hub, as well as our efforts to expand our research integrity team and explore proactive measures.

Closing Thoughts

MDPI Thought Leadership Op-ed on Open Access is Now Live on Politico

I am pleased to share that our thought leadership Op-ed piece on Open Access (OA) is now live on Politico. This is a nice push for continued influence and support of OA among policymakers and industry leaders.

Why Politico?

Politico's reputation as a highly credible and influential news platform makes it an important venue to reach key opinion leaders (KOL) from academia, policymakers, and thought leaders from many industries. This visibility helps promote the OA philosophy.

Open Access: A Moral Imperative for Progress

In this piece, I discuss the necessity of making scientific research freely available to all. I argue that publicly funded research should be publicly accessible, highlighting how OA democratizes scientific knowledge, accelerates research availability, and fosters collaboration.

“Open Access is a fundamental right for all citizens”

Democratizing scientific communication
The impulse to democratize scientific communication is nothing new. OA may seem like a recent innovation, but its principles have historical roots traceable to Europe in the 15th century. Just as the printing revolution accelerated the dissemination of new ideas, OA publishing unlocks new scientific insights that would otherwise only be accessible to a few.

Benefits for scholars: amplifying impact through Open Access
Authors publishing in an OA journal can expect more citations of their work, increasing its potential impact. Research findings that are freely available are more likely to be cited than those hidden behind a paywall. Freedom of access greatly increases the potential audience for each paper, fostering a sense of community among researchers worldwide. Heightened visibility can attract prospective collaborators and employers for young scientists. At MDPI, we believe that all these factors can only accelerate the advance of science. Additionally, authors retain copyright in their work instead of signing it away, permitting broader dissemination under Creative Commons licenses and increasing its capacity for impact.

The moral imperative
OA is not just a matter of scientific policy; it is a fundamental right for all citizens and a prerequisite for a brighter, more informed future. Publicly funded research should be a top priority, and I am pleased to see policy moving in this direction. Our capacity to generate transformative scientific insights has to be democratized. The question today is no longer whether we can afford to embrace OA; rather, it is whether we can afford not to.

Stefan Tochev
Chief Executive Officer
MDPI AG

2 August 2024
MDPI Romania Author Training Sessions in May

In May, MDPI Romania held three author training sessions – one endorsing an external event and two stand-alone sessions.

The National Session of Scientific Student Communications took place at Technical University Cluj on 17 and 18 May 2024. MDPI Romania sponsored this event and contributed an author training session on the production of research papers and case study analyses. JRS Norbert Kiss gave a presentation called The World of Open Access to explain different open access publishing models and the benefits of open access publishing. His presentation highlighted the impact of open access publishing on scientific progress and innovation.

On 29 May 2024, MDPI Romania hosted an author training session for Ph.D. students, early career researchers, and professors at the Carol Davila University of Medicine and Pharmacy. In collaboration with Prof. Andreea Arsene, JRS Ioana Paunescu prepared two presentations: The Steps of the Publishing Process and Elaboration of a Peer Review Report. In her first presentation, she delved into MDPI’s history and mission, MDPI’s editorial process, and MDPI journals of various scopes that are accepting submissions. Her second presentation outlined the types of peer review, the contents of a peer review report by an MDPI reviewer, and the responsibilities of an MDPI reviewer.

MDPI Romania also hosted an author training session at the Iasi University of Life Sciences on 29 May 2024. JRSs Laurentiu Preda and Cosmin Artan gave four presentations: Efficient Writing of an ISI-Indexed Scientific Article, Benefits of Publishing in the Open Access Model, Various Methods of Open Access Publishing, and MDPI Guide for the Article Review Process. The first three presentations offered guidance on how to improve academic writing, the fourth focused on how to write peer review reports. A highly interactive discussion followed the presentations, during which the JRSs provided extensive answers to attendees’ questions.

MDPI is grateful for all the attendees, speakers, and organizers involved in these events. Through their enthusiasm and dedication, these events were great successes.

19 July 2024
Meet Us at the Plant Genomics in China XXII, 19–22 August 2024, Hainan, China


Conference:
 Plant Genomics in China XXII
Organization: Genetic Society of China
Date: 19–22 August 2024
Place: Haikou, Hainan, China

MDPI journals will be attending Plant Genomics in China XXII as exhibitors. This meeting will be held in Haikou, Hainan, China, from 19 to 22 August 2024.

In order to fully demonstrate the latest achievements and progress in the field of plant genome research and promote the in-depth research of plant genomics in the country and the rapid development of the agricultural biotechnology industry, the 23rd National Congress is scheduled to be held in Haikou, Hainan, from August 19 to 22, 2024. The conference will invite experts, scholars and outstanding young scientists at home and abroad who have made outstanding achievements in plant genomics-related fields and have important academic influence to give academic reports. The language of the conference report is English. The organizing committee invites domestic and foreign colleagues and graduate students from relevant universities and research institutes to participate in this conference. This conference is the largest high-level academic event in the field of genetics research in China. This conference invites famous scholars, experts, young talents and entrepreneurs in the field of genetics to conduct in-depth exchanges.

The following MDPI journals will be represented:

If you will be attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

19 July 2024
Meet Us at the 46th Congress of the Spanish Society of Biochemistry and Molecular Biology, 3–6 September 2024, A Coruña, Spain


MDPI will be attending the 46th Congress of the Spanish Society of Biochemistry and Molecular biology (46th SEBBM Congress), which will be held from 3 to 6 September 2024 in A Coruña, Spain.

The 46th SEBBM Congress will enjoy a wide range of plenary conferences, symposia, including the Hispanic-Luso Scientific Symposium and the Scientific Symposium of Education, meetings of the scientific groups of SEBBMs, poster sessions and the commercial exhibition of collaborating companies. We will be able to enjoy satellite activities such as the Research Initiation Course in Biochemistry and Molecular Biology, the Professional Development Forum for Young Researchers, and the activities of Biochemistry in the city, with exhibitions, scientific–artistic shows, round tables and scientific workshops.

The following MDPI journals will be represented at the conference:

If you are planning to attend the above conference, we encourage you to visit our booth and speak to our representatives. We are eager to meet you in person and assist you with any queries that you may have.

For more information about the conference, please visit the official website at https://congresos.sebbm.es/coruna2024/.

17 July 2024
The 30th International Conference on Magnetic Resonance in Biological Systems (ICMRBS 2024), 18–23 August 2024, Seoul, Republic of Korea


Conference: The 30th International Conference on Magnetic Resonance in Biological Systems (ICMRBS 2024)
Date: 18–23 August 2024
Place: COEX, Seoul, Republic of Korea
Organized by: Korean Magnetic Resonance Society (KMRS)
Conference Award: “MDPI Biomolecules Poster Award” sponsored by Biomolecules (ISSN: 2218-273X)

The International Council on Magnetic Resonance in Biological Systems (ICMRBS) organizes biennial conferences that have grown substantially in both size and scope since the initial meeting in 1964. Besides covering important new developments in the use of EPR and in vivo NMR, the meeting is widely considered one of the premier meetings in the rapidly growing field of protein and nucleic acid structure determination by multi-dimensional NMR techniques.

We would especially like to invite young researchers, including M.Sc. students, Ph.D. students, and post-docs, as we think this will be a great opportunity for them to share their scientific experience and interact with our network.

For more information, please visit the following link: https://www.icmrbs2024.org/.

10 July 2024
MDPI's Newly Launched Journals in June 2024

Five new journals covering multiple subjects have launched their inaugural issue in June 2024. We are excited to be able to share with you the newest research rooted in the value of open access.

We would like to express our deepest appreciation to all the Editorial Board Members and each journal will ensure its high-quality output using excellent editorial and rigorous peer review processes, to ensure that the articles achieve high impact and visibility.

Please feel free to browse and discover more about the new journals below.

Journal

Founding Editor-in-Chief

Journal Topics (Selected)

Anesthesia Research Logo

Prof. Dr. Marco Ranucci, IRCCS Policlinico San Donato, Italy
| Editorial | view inaugural issue

anaesthetic medications; blood and fluid management; pain management; critical care; critical illness | view journal scope | submit an article

Complications Logo

Dr. Giovanni E. Cacciamani, University of Southern California, USA
| Editorial | view inaugural issue

surgical/procedural complications; complications; perioperative adverse events; postoperative adverse events | view journal scope | submit an article

Laboratories Logo

Prof. Dr.  Gassan Hodaifa, Universidad Pablo de Olavide, Spain
| Editorial | view inaugural issue

laboratory management; laboratory safety; protective equipment; laboratory problems and challenges; laboratory Innovation | view journal scope | submit an article

Pets Logo

Prof. Dr. Jan S. Suchodolski, Texas A&M University, USA
| Editorial | view inaugural issue

companion animals health and disease; veterinary care and nutrition; genetics and genomics; behavior and welfare; human-animal relations | view journal scope | submit an article

Real Estate Logo

Prof. Dr. Pierfrancesco De Paola, University of Naples Federico II, Italy
| Editorial | view inaugural issue

real estate appraisal; economic and financial valuation of real estate projects; sustainable real estate; housing and urban economics | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here, or contact the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.

Back to TopTop